NCT01897961View on ClinicalTrials.gov

Phospholipase A2 Receptor (PLA2R1) Autoantibodies in Membranous Nephropathy in Kidney Transplantation

NACompletedINTERVENTIONAL
Enrollment

137

Participants

Timeline

Start Date

January 10, 2012

Primary Completion Date

March 3, 2018

Study Completion Date

March 3, 2018

Conditions
Kidney Transplantation
Interventions
OTHER

Anticorps anti-PLA2R1

Trial Locations (1)

06000

CHU de Nice, Nice

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT01897961 - Phospholipase A2 Receptor (PLA2R1) Autoantibodies in Membranous Nephropathy in Kidney Transplantation | Biotech Hunter | Biotech Hunter